| Baseball and Biopharma: More Alike Than You Might Realize | Stewart Lyman | 07/03/13 | Seattle |
| Women in Bio, After Gaining Momentum Elsewhere, Arrives in SF | Luke Timmerman | 03/13/12 | San Francisco |
| Nektar Pockets $220M | Luke Timmerman | 01/24/11 | San Francisco |
| Hyperion Nails Pivotal Trial, ChemoCentryx Aims High Against Crohn’s, Vivus Shot Down by FDA, & More Bay Area Life Sciences News | Luke Timmerman | 11/05/10 | San Francisco |
| Nektar Gets $50M Deal From Amgen | Luke Timmerman | 11/02/10 | San Francisco |
| The Mission Bay Biotech Cluster: Antibodies, RNAi, Biofuels, & More | Luke Timmerman | 06/29/10 | San Francisco |
| Alkermes Reveals Higher-Than-Expected Royalty on Diabetes Drug | Luke Timmerman | 04/26/10 | Boston |
| Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News | Erin Kutz | 04/16/10 | Boston |
| MicroCHIPS, Nimbit, and Xcellerex Hire New CEOs | Erin Kutz | 04/13/10 | Boston |
